Cancer Cachexia Market – Industry Analysis and forecast (2019 to 2027) – By Therapeutics, Mechanism of action, Distribution Channel, and Region

Market Scenario

Cancer Cachexia Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2027, at CAGR of 5.4 % during forecast period of 2019 to 2027. Cancer Cachexia Market Cancer cachexia is defined as an ongoing loss of skeletal muscle mass with or without loss of fat mass that cannot be completely reversed by conventional nutritional support and leads to progressive functional damage. Continuing clinical trials in oncology have shed light on multifactorial pathogenicity of the syndrome cancer cachexia. Understanding the mechanism of cancer cachexia has become imperious for the understanding of prognostic issues for cancer. Pharmaceuticals seeking stronghold in the global market. Cachexia is an often permanent side effect of diseases including cancer and HIV. Cancer cachexia market have adopted strategies that fast-track time-to-market of novel pharmaceutical agents.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. Cancer cachexia Market Drivers and Restrains Leading players are entering into mergers with acquisitions of organizations engaging in clinical trials. These strategies support the development of new multidisciplinary combination therapies, thus aiding them to consolidate their shares. In a progressively competitive market, companies that compete for sizable shares in the cancer cachexia market include Eli Lilly and Co., Aphios Corp., Novartis, Merck Co. Inc., Alder BioPharmaceuticals Inc., and Aeterna Zentaris. The growth of the global cancer cachexia market is powered by wide research on using multiple agents for treating metabolic abnormalities in cachexia. Expansion of these multiple pharmacologic agents will further collect steam on the back of regulatory landscape. Manufacturers in the Cancer cachexia are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers. Cancer cachexia Market Segmentation Analysis The global cancer cachexia market is segmented on the basis of Therapeutics, Mechanism of action, Distribution Channel, and Region. The Cancer cachexia Market therapeutics Market, is sub segmented into progestogens, corticosteroids, combination therapies and others. Corticosteroids segment is expected to grow at the highest XX% CAGR during the forecast period. Because of Corticosteroids containing medicines are used to provide relief for inflamed areas of the body, such as swelling, redness, itching, and allergic reactions. They are habitually used as part of the treatment for a number of different diseases, like severe allergies or skin problems, asthma, or arthritis. Based on mechanism of action the cancer cachexia market is divided into as appetite stimulators, weight loss stabilizers and others. In terms of distribution channel the market is sub segmented as hospital stores, retail pharmacy store and online pharmacy. Tumor necrosis factor alpha (TNF-α), IL-1 (interleukin 1), IL-6 (interleukin 6) and interferon-gamma (IFN-γ) are the common cytokines implicated in cachexia. Cancer cachexia Market Regional Analysis On the basis of region Cancer cachexia Market divided into five region such as Asia Pacific, North America, Europe, Latin America, and Middle East Africa. Among all the regions, North America had hold the largest market share in 2018 and is projected to lead the market during the forecast period. Because of the pipeline of pharmacologic agents is ready in North America. Large part of the increasing impetus comes from advancing paradigm of care for cancer patients. Furthermore, the occurrence of cachexia in Japan and Europe will make these key cancer cachexia markets during the forecast period. Developing regions, particularly Asia Pacific, have vast pool of patients with Cancer cachexia. This is a strong factor underpinning research into understanding the etiology of underlying cancer cachexia. Hence, Asia Pacific is expected to be the second largest market over the forecast period and nearly follow by North America in terms of profits. The objective of the report is to present comprehensive analysis of Cancer cachexia Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Cancer cachexia Market dynamics, structure by analyzing the market segments, and project the Cancer cachexia Market size. Clear representation of competitive analysis of key players by Cancer cachexia Type, price, financial position, product portfolio, growth strategies, and regional presence in the Cancer cachexia Market make the report investor’s guide.

Scope of the Cancer cachexia Market

Cancer cachexia Market, by Therapeutics

• Progestogens • Corticosteroids • Combination Therapies • Others

Cancer cachexia Market, by Mechanism of action

• Appetite Stimulators • Weight Loss Stabilizers • Others

Cancer cachexia Market, by Distribution Channel

• Hospital Stores • Retail Pharmacy Stores • Online Pharmacy

Cancer cachexia Market, by Region

• Asia Pacific • North America • Europe • Latin America • Middle East Africa

Cancer cachexia Market, Major Players

• Eterna Zentaris Inc. • Alder BioPharmaceuticals Inc. • Aphios Corporation • Eli Lilly and Company • GTx Inc. • Helsinn Group • Merck & Co. Inc. • Novartis AG • Bristol-Myers Squibb Company • XBiotech, Inc. • Neurim • Pernix Therapeutics • Pfizer Inc • Purdue Pharma L.P. • Sanofi Pasteur • SkyePharma • Takeda Pharmaceutical Company

Table of Contents

Cancer Cachexia Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Cancer Cachexia Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Cancer Cachexia Market Analysis and Forecast 6.1. Global Cancer Cachexia Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Cancer Cachexia Market Analysis and Forecast, by Therapeutics 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Cancer Cachexia Market Value Share Analysis, by Therapeutics 7.4. Global Cancer Cachexia Market Size (US$ Bn) Forecast, by Therapeutics 7.5. Global Cancer Cachexia Market Analysis, by Therapeutics 7.6. Global Cancer Cachexia Market Attractiveness Analysis, by Therapeutics 8. Global Cancer Cachexia Market Analysis and Forecast, by Mechanism of action 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Cancer Cachexia Market Value Share Analysis, by Mechanism of action 8.4. Global Cancer Cachexia Market Size (US$ Bn) Forecast, by Mechanism of action 8.5. Global Cancer Cachexia Market Analysis, by Mechanism of action 8.6. Global Cancer Cachexia Market Attractiveness Analysis, by Mechanism of action 9. Global Cancer Cachexia Market Analysis and Forecast, by Distribution Channel 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Cancer Cachexia Market Value Share Analysis, by Distribution Channel 9.4. Global Cancer Cachexia Market Size (US$ Bn) Forecast, by Distribution Channel 9.5. Global Cancer Cachexia Market Analysis, by Distribution Channel 9.6. Global Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel 10. Global Cancer Cachexia Market Analysis, by Region 10.1. Global Cancer Cachexia Market Value Share Analysis, by Region 10.2. Global Cancer Cachexia Market Size (US$ Bn) Forecast, by Region 10.3. Global Cancer Cachexia Market Attractiveness Analysis, by Region 11. North America Cancer Cachexia Market Analysis 11.1. Key Findings 11.2. North America Cancer Cachexia Market Overview 11.3. North America Cancer Cachexia Market Value Share Analysis, by Therapeutics 11.4. North America Cancer Cachexia Market Forecast, by Therapeutics 11.4.1. Progestogens 11.4.2. Corticosteroids 11.4.3. Combination Therapies 11.4.4. Others 11.5. North America Cancer Cachexia Market Value Share Analysis, by Mechanism of action 11.6. North America Cancer Cachexia Market Forecast, by Mechanism of action 11.6.1. Appetite Stimulators 11.6.2. Weight Loss Stabilizers 11.6.3. Others` 11.7. North America Cancer Cachexia Market Value Share Analysis, by Distribution Channel 11.8. North America Cancer Cachexia Market Forecast, by Distribution Channel 11.8.1. Hospital Stores 11.8.2. Retail Pharmacy Stores 11.8.3. Online Pharmacy 11.9. North America Cancer Cachexia Market Value Share Analysis, by Country 11.10. North America Cancer Cachexia Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Cancer Cachexia Market Analysis, by Country 11.12. U.S. Cancer Cachexia Market Forecast, by Therapeutics 11.12.1. Progestogens 11.12.2. Corticosteroids 11.12.3. Combination Therapies 11.12.4. Others 11.12.5. Maggot/Biotherapy Method 11.12.6. Others 11.13. U.S. Cancer Cachexia Market Forecast, by Mechanism of action 11.13.1. Appetite Stimulators 11.13.2. Weight Loss Stabilizers 11.13.3. Others 11.14. U.S. Cancer Cachexia Market Forecast, by Distribution Channel 11.14.1. Hospital Stores 11.14.2. Retail Pharmacy Stores 11.14.3. Online Pharmacy 11.15. Canada Cancer Cachexia Market Forecast, by Therapeutics 11.15.1. Progestogens 11.15.2. Corticosteroids 11.15.3. Combination Therapies 11.15.4. Others 11.16. Steel Canada Cancer Cachexia Market Forecast, by Mechanism of action 11.16.1. Appetite Stimulators 11.16.2. Weight Loss Stabilizers 11.16.3. Others 11.17. Canada Cancer Cachexia Market Forecast, by Distribution Channel 11.17.1. Hospital Stores 11.17.2. Retail Pharmacy Stores 11.17.3. Online Pharmacy 11.18. North America Cancer Cachexia Market Attractiveness Analysis 11.18.1. By Therapeutics 11.18.2. By Mechanism of action 11.18.3. By Distribution Channel 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Cancer Cachexia Market Analysis 12.1. Key Findings 12.2. Europe Cancer Cachexia Market Overview 12.3. Europe Cancer Cachexia Market Value Share Analysis, by Therapeutics 12.4. Europe Cancer Cachexia Market Forecast, by Therapeutics 12.4.1. Progestogens 12.4.2. Corticosteroids 12.4.3. Combination Therapies 12.4.4. Others 12.4.5. Maggot/Biotherapy Method 12.4.6. Others 12.5. Europe Cancer Cachexia Market Value Share Analysis, by Mechanism of action 12.6. Europe Cancer Cachexia Market Forecast, by Mechanism of action 12.6.1. Appetite Stimulators 12.6.2. Weight Loss Stabilizers 12.6.3. Others 12.7. Europe Cancer Cachexia Market Value Share Analysis, by Distribution Channel 12.8. Europe Cancer Cachexia Market Forecast, by Distribution Channel 12.8.1. Hospital Stores 12.8.2. Retail Pharmacy Stores 12.8.3. Online Pharmacy 12.9. Europe Cancer Cachexia Market Value Share Analysis, by Country 12.10. Europe Cancer Cachexia Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Cancer Cachexia Market Analysis, by Country 12.12. Germany Cancer Cachexia Market Forecast, by Therapeutics 12.12.1. Progestogens 12.12.2. Corticosteroids 12.12.3. Combination Therapies 12.12.4. Others 12.12.5. Maggot/Biotherapy Method 12.12.6. Others 12.13. Germany Cancer Cachexia Market Forecast, by Mechanism of action 12.13.1. Appetite Stimulators 12.13.2. Weight Loss Stabilizers 12.13.3. Others 12.14. Germany Cancer Cachexia Market Forecast, by Distribution Channel 12.14.1. Hospital Stores 12.14.2. Retail Pharmacy Stores 12.14.3. Online Pharmacy 12.15. U.K. Cancer Cachexia Market Forecast, by Therapeutics 12.15.1. Progestogens 12.15.2. Corticosteroids 12.15.3. Combination Therapies 12.15.4. Others 12.15.5. Maggot/Biotherapy Method 12.15.6. Others 12.16. U.K. Cancer Cachexia Market Forecast, by Mechanism of action 12.16.1. Appetite Stimulators 12.16.2. Weight Loss Stabilizers 12.16.3. Others 12.17. U.K. Cancer Cachexia Market Forecast, by Distribution Channel 12.17.1. Hospital Stores 12.17.2. Retail Pharmacy Stores 12.17.3. Online Pharmacy 12.18. France Cancer Cachexia Market Forecast, by Therapeutics 12.18.1. Progestogens 12.18.2. Corticosteroids 12.18.3. Combination Therapies 12.18.4. Others 12.18.5. Maggot/Biotherapy Method 12.18.6. Others 12.19. France Cancer Cachexia Market Forecast, by Mechanism of action 12.19.1. Appetite Stimulators 12.19.2. Weight Loss Stabilizers 12.19.3. Others 12.20. France Cancer Cachexia Market Forecast, by Distribution Channel 12.20.1. Hospital Stores 12.20.2. Retail Pharmacy Stores 12.20.3. Online Pharmacy 12.21. Italy Cancer Cachexia Market Forecast, by Therapeutics 12.21.1. Progestogens 12.21.2. Corticosteroids 12.21.3. Combination Therapies 12.21.4. Others 12.21.5. Maggot/Biotherapy Method 12.21.6. Others 12.22. Italy Cancer Cachexia Market Forecast, by Mechanism of action 12.22.1. Appetite Stimulators 12.22.2. Weight Loss Stabilizers 12.22.3. Others 12.23. Italy Cancer Cachexia Market Forecast, by Distribution Channel 12.23.1. Hospital Stores 12.23.2. Retail Pharmacy Stores 12.23.3. Online Pharmacy 12.24. Spain Cancer Cachexia Market Forecast, by Therapeutics 12.24.1. Progestogens 12.24.2. Corticosteroids 12.24.3. Combination Therapies 12.24.4. Others 12.24.5. Maggot/Biotherapy Method 12.24.6. Others 12.25. Spain Cancer Cachexia Market Forecast, by Mechanism of action 12.25.1. Appetite Stimulators 12.25.2. Weight Loss Stabilizers 12.25.3. Others 12.26. Spain Cancer Cachexia Market Forecast, by Distribution Channel 12.26.1. Hospital Stores 12.26.2. Retail Pharmacy Stores 12.26.3. Online Pharmacy 12.27. Rest of Europe Cancer Cachexia Market Forecast, by Therapeutics 12.27.1. Progestogens 12.27.2. Corticosteroids 12.27.3. Combination Therapies 12.27.4. Others 12.27.5. Maggot/Biotherapy Method 12.27.6. Others 12.28. Rest of Europe Cancer Cachexia Market Forecast, by Mechanism of action 12.28.1. Appetite Stimulators 12.28.2. Weight Loss Stabilizers 12.28.3. Others 12.29. Rest Of Europe Cancer Cachexia Market Forecast, by Distribution Channel 12.29.1. Hospital Stores 12.29.2. Retail Pharmacy Stores 12.29.3. Online Pharmacy 12.30. Europe Cancer Cachexia Market Attractiveness Analysis 12.30.1. By Therapeutics 12.30.2. By Mechanism of action 12.30.3. By Distribution Channel 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Cancer Cachexia Market Analysis 13.1. Key Findings 13.2. Asia Pacific Cancer Cachexia Market Overview 13.3. Asia Pacific Cancer Cachexia Market Value Share Analysis, by Therapeutics 13.4. Asia Pacific Cancer Cachexia Market Forecast, by Therapeutics 13.4.1. Progestogens 13.4.2. Corticosteroids 13.4.3. Combination Therapies 13.4.4. Others 13.4.5. Maggot/Biotherapy Method 13.4.6. Others 13.5. Asia Pacific Cancer Cachexia Market Value Share Analysis, by Mechanism of action 13.6. Asia Pacific Cancer Cachexia Market Forecast, by Mechanism of action 13.6.1. Appetite Stimulators 13.6.2. Weight Loss Stabilizers 13.6.3. Others 13.7. Asia Pacific Cancer Cachexia Market Value Share Analysis, by Distribution Channel 13.8. Asia Pacific Cancer Cachexia Market Forecast, by Distribution Channel 13.8.1. Hospital Stores 13.8.2. Retail Pharmacy Stores 13.8.3. Online Pharmacy 13.9. Asia Pacific Cancer Cachexia Market Value Share Analysis, by Country 13.10. Asia Pacific Cancer Cachexia Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Cancer Cachexia Market Analysis, by Country 13.12. China Cancer Cachexia Market Forecast, by Therapeutics 13.12.1. Progestogens 13.12.2. Corticosteroids 13.12.3. Combination Therapies 13.12.4. Others 13.12.5. Maggot/Biotherapy Method 13.12.6. Others 13.13. China Cancer Cachexia Market Forecast, by Mechanism of action 13.13.1. Appetite Stimulators 13.13.2. Weight Loss Stabilizers 13.13.3. Others 13.14. China Cancer Cachexia Market Forecast, by Distribution Channel 13.14.1. Hospital Stores 13.14.2. Retail Pharmacy Stores 13.14.3. Online Pharmacy 13.15. India Cancer Cachexia Market Forecast, by Therapeutics 13.15.1. Progestogens 13.15.2. Corticosteroids 13.15.3. Combination Therapies 13.15.4. Others 13.15.5. Maggot/Biotherapy Method 13.15.6. Others 13.16. India Cancer Cachexia Market Forecast, by Mechanism of action 13.16.1. Appetite Stimulators 13.16.2. Weight Loss Stabilizers 13.16.3. Others 13.17. India Cancer Cachexia Market Forecast, by Distribution Channel 13.17.1. Hospital Stores 13.17.2. Retail Pharmacy Stores 13.17.3. Online Pharmacy 13.18. Japan Cancer Cachexia Market Forecast, by Therapeutics 13.18.1. Progestogens 13.18.2. Corticosteroids 13.18.3. Combination Therapies 13.18.4. Others 13.18.5. Maggot/Biotherapy Method 13.18.6. Others 13.19. Japan Cancer Cachexia Market Forecast, by Mechanism of action 13.19.1. Appetite Stimulators 13.19.2. Weight Loss Stabilizers 13.19.3. Others 13.20. Japan Cancer Cachexia Market Forecast, by Distribution Channel 13.20.1. Hospital Stores 13.20.2. Retail Pharmacy Stores 13.20.3. Online Pharmacy 13.21. ASEAN Cancer Cachexia Market Forecast, by Therapeutics 13.21.1. Progestogens 13.21.2. Corticosteroids 13.21.3. Combination Therapies 13.21.4. Others 13.21.5. Maggot/Biotherapy Method 13.21.6. Others 13.22. ASEAN Cancer Cachexia Market Forecast, by Mechanism of action 13.22.1. Appetite Stimulators 13.22.2. Weight Loss Stabilizers 13.22.3. Others 13.23. ASEAN Cancer Cachexia Market Forecast, by Distribution Channel 13.23.1. Hospital Stores 13.23.2. Retail Pharmacy Stores 13.23.3. Online Pharmacy 13.24. Rest of Asia Pacific Cancer Cachexia Market Forecast, by Therapeutics 13.24.1. Progestogens 13.24.2. Corticosteroids 13.24.3. Combination Therapies 13.24.4. Others 13.24.5. Maggot/Biotherapy Method 13.24.6. Others 13.25. Rest of Asia Pacific Cancer Cachexia Market Forecast, by Mechanism of action 13.25.1. Appetite Stimulators 13.25.2. Weight Loss Stabilizers 13.25.3. Others 13.26. Rest of Asia Pacific Cancer Cachexia Market Forecast, by Distribution Channel 13.26.1. Hospital Stores 13.26.2. Retail Pharmacy Stores, Online Pharmacy 13.27. Asia Pacific Cancer Cachexia Market Attractiveness Analysis 13.27.1. By Therapeutics 13.27.2. By Mechanism of action 13.27.3. By Distribution Channel 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Cancer Cachexia Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Cancer Cachexia Market Overview 14.3. Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Therapeutics 14.4. Middle East & Africa Cancer Cachexia Market Forecast, by Therapeutics 14.4.1. Progestogens 14.4.2. Corticosteroids 14.4.3. Combination Therapies 14.4.4. Others 14.4.5. Maggot/Biotherapy Method 14.4.6. Others 14.5. Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Mechanism of action 14.6. Middle East & Africa Cancer Cachexia Market Forecast, by Mechanism of action 14.6.1. Appetite Stimulators 14.6.2. Weight Loss Stabilizers 14.6.3. Others 14.7. Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Distribution Channel 14.8. Middle East & Africa Cancer Cachexia Market Forecast, by Distribution Channel 14.8.1. Hospital Stores 14.8.2. Retail Pharmacy Stores 14.8.3. Online Pharmacy 14.9. Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Country 14.10. Middle East & Africa Cancer Cachexia Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Cancer Cachexia Market Analysis, by Country 14.12. GCC Cancer Cachexia Market Forecast, by Therapeutics 14.12.1. Progestogens 14.12.2. Corticosteroids 14.12.3. Combination Therapies 14.12.4. Others 14.12.5. Maggot/Biotherapy Method 14.12.6. Others 14.13. GCC Cancer Cachexia Market Forecast, by Mechanism of action 14.13.1. Appetite Stimulators 14.13.2. Weight Loss Stabilizers 14.13.3. Others 14.14. GCC Cancer Cachexia Market Forecast, by Distribution Channel 14.14.1. Hospital Stores 14.14.2. Retail Pharmacy Stores, Online Pharmacy 14.15. South Africa Cancer Cachexia Market Forecast, by Therapeutics 14.15.1. Progestogens 14.15.2. Corticosteroids 14.15.3. Combination Therapies 14.15.4. Others 14.15.5. Maggot/Biotherapy Method 14.15.6. Others 14.16. South Africa Cancer Cachexia Market Forecast, by Mechanism of action 14.16.1. Appetite Stimulators 14.16.2. Weight Loss Stabilizers 14.16.3. Others 14.17. South Africa Cancer Cachexia Market Forecast, by Distribution Channel 14.17.1. Hospital Stores 14.17.2. Retail Pharmacy Stores 14.17.3. Online Pharmacy 14.18. Rest of Middle East & Africa Cancer Cachexia Market Forecast, by Therapeutics 14.18.1. Progestogens 14.18.2. Corticosteroids 14.18.3. Combination Therapies 14.18.4. Others 14.18.5. Maggot/Biotherapy Method 14.18.6. Others 14.19. Rest of Middle East & Africa Cancer Cachexia Market Forecast, by Mechanism of action 14.19.1. Appetite Stimulators 14.19.2. Weight Loss Stabilizers 14.19.3. Others 14.20. Rest of Middle East & Africa Cancer Cachexia Market Forecast, by Distribution Channel 14.20.1. Hospital Stores 14.20.2. Retail Pharmacy Stores 14.20.3. Online Pharmacy 14.21. Middle East & Africa Cancer Cachexia Market Attractiveness Analysis 14.21.1. By Therapeutics 14.21.2. By Mechanism of action 14.21.3. By Distribution Channel 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Cancer Cachexia Market Analysis 15.1. Key Findings 15.2. South America Cancer Cachexia Market Overview 15.3. South America Cancer Cachexia Market Value Share Analysis, by Therapeutics 15.4. South America Cancer Cachexia Market Forecast, by Therapeutics 15.4.1. Progestogens 15.4.2. Corticosteroids 15.4.3. Combination Therapies 15.4.4. Others 15.4.5. Maggot/Biotherapy Method 15.4.6. Others 15.5. South America Cancer Cachexia Market Value Share Analysis, by Mechanism of action 15.6. South America Cancer Cachexia Market Forecast, by Mechanism of action 15.6.1. Appetite Stimulators 15.6.2. Weight Loss Stabilizers 15.6.3. Others 15.7. South America Cancer Cachexia Market Value Share Analysis, by Distribution Channel 15.8. South America Cancer Cachexia Market Forecast, by Distribution Channel 15.8.1. Hospital Stores 15.8.2. Retail Pharmacy Stores 15.8.3. Online Pharmacy 15.9. South America Cancer Cachexia Market Value Share Analysis, by Country 15.10. South America Cancer Cachexia Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Cancer Cachexia Market Analysis, by Country 15.12. Brazil Cancer Cachexia Market Forecast, by Therapeutics 15.12.1. Progestogens 15.12.2. Corticosteroids 15.12.3. Combination Therapies 15.12.4. Others 15.12.5. Maggot/Biotherapy Method 15.12.6. Others 15.13. Brazil Cancer Cachexia Market Forecast, by Mechanism of action 15.13.1. Appetite Stimulators 15.13.2. Weight Loss Stabilizers 15.13.3. Others 15.14. Brazil Cancer Cachexia Market Forecast, by Distribution Channel 15.14.1. Hospital Stores 15.14.2. Retail Pharmacy Stores 15.14.3. Online Pharmacy 15.15. Mexico Cancer Cachexia Market Forecast, by Therapeutics 15.15.1. Progestogens 15.15.2. Corticosteroids 15.15.3. Combination Therapies 15.15.4. Others 15.15.5. Maggot/Biotherapy Method 15.15.6. Others 15.16. Mexico Cancer Cachexia Market Forecast, by Mechanism of action 15.16.1. Appetite Stimulators 15.16.2. Weight Loss Stabilizers 15.16.3. Others 15.17. Mexico Cancer Cachexia Market Forecast, by Distribution Channel 15.17.1. Hospital Stores 15.17.2. Retail Pharmacy Stores 15.17.3. Online Pharmacy 15.18. Rest of South America Cancer Cachexia Market Forecast, by Therapeutics 15.18.1. Progestogens 15.18.2. Corticosteroids 15.18.3. Combination Therapies 15.18.4. Others 15.18.5. Maggot/Biotherapy Method 15.18.6. Others 15.19. Rest of South America Cancer Cachexia Market Forecast, by Mechanism of action 15.19.1. Appetite Stimulators 15.19.2. Weight Loss Stabilizers 15.19.3. Others 15.20. others Rest of South America Cancer Cachexia Market Forecast, by Distribution Channel 15.20.1. Hospital Stores 15.20.2. Retail Pharmacy Stores 15.20.3. Online Pharmacy 15.21. South America Cancer Cachexia Market Attractiveness Analysis 15.21.1. By Therapeutics 15.21.2. By Mechanism of action 15.21.3. By Distribution Channel 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Eterna Zentaris Inc. 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Alder BioPharmaceuticals Inc. 16.3.3. Aphios Corporation 16.3.4. Eli Lilly and Company 16.3.5. GTx Inc. 16.3.6. Helsinn Group 16.3.7. Merck & Co. Inc. 16.3.8. Novartis AG 16.3.9. Bristol-Myers Squibb Company 16.3.10. XBiotech, Inc. 16.3.11. Neurim 16.3.12. Pernix Therapeutics 16.3.13. Pfizer Inc 16.3.14. Purdue Pharma L.P. 16.3.15. Sanofi Pasteur 16.3.16. SkyePharma 16.3.17. Takeda Pharmaceutical Company 17. Primary Key Insights

About This Report

Report ID 37294
Category Healthcare
Published Date
No of Pages 191
Contact Us